In light of the Egyptian Drug Authority's continuous commitment to keeping pace with modern scientific developments to ensure the availability of advanced, high-tech products while guaranteeing their quality, efficacy, and safety, the Egyptian Drug Authority – Central Administration for Biological and Innovative Products and Clinical Trials announces the publication of a public Consultation for the draft of the following regulatory guide:"Procedures for registration of biological products through reliance pathways".We are honored to receive the "Stakeholder feedback form" at the following email address: Biots.da@edaegypt.gov.eg, from June 10, 2026, to June 21, 2026.

To review the draft regulatory guide, please click on the link